GC녹십자웰빙

GC녹십자웰빙 held a groundbreaking ceremony on November 2, 2026 for a new medical device GMP plant in Eumseong, Chungcheongbuk-do, South Korea. The facility will produce fillers and skin boosters with an annual capacity of up to 3 million units, with completion targeted for Q2 2027.